Safflower oil might have a negative influence in patients with diabetes although experts should conduct more studies in this regard.
Cla safflower oil diet side effects.
Kidney damage in people with diabetes diabetic nephropathy.
A grouping of symptoms that increase the risk of diabetes heart disease and stroke metabolic syndrome.
While it can definitely be included in moderation as part of a balanced diet consuming high amounts can increase your calorie consumption which could contribute to weight gain.
However the safety of probiotics when undergoing chemo is not well established so before supplementing your diet with fermented foods or taking probiotics discuss risks and benefits with your cancer.
What s more studies have linked cla supplements with several adverse effects.
Castillo notes that cla can increase c reactive protein which is associated with inflammation and liver damage.
Large doses of cla such as the amount provided in supplements have been linked to insulin resistance decreased.
Safflower is used to treat symptoms of high blood pressure diabetes cystic fibrosis or fatty acid deficiency and as an anti coagulant.
Furthermore safflower oil is very high in fat and calories.
According to wellness bleeding stomach problems and intestinal disturbance have been reported as adverse reactions after taking safflower oil.
A small number of people suffering from kidney diseases have reported side effects.
Also pregnant women should avoid it as it can cause miscarriage.
Safflower oil does not seem to affect insulin levels or insulin sensitivity.
Taking conjugated linoleic acid for 90 days along with dieting seems to decrease body fat.
Cla safflower oil safety and side effects cla safety has been evaluated in several well conducted animal toxicologic studies.
What s more probiotics are linked to alleviating cancer treatment associated side effects according to memorial sloan kettering cancer center.
A comparison review was conducted on 64 studies involving mice rats hamsters or humans that focused on the effect of cla on hepatic steatosis and hepatic and adipose lipid.
Scimeca 82 conducted a 36 wk feeding trial in which fischer 344 rats were fed either control diet or diet supplemented with 1 5 cla a level 30 times greater than humans would ingest at 3 g cla d.
